Borot, F., Humbert, O., Ehmsen, J. T., Fields, E., Kohli, S., Radtke, S., Swing, K., Pande, D., Enstrom, M. R., Laszlo, G. S., Mayuranathan, T., Ali, A. M., Weiss, M. J., Yen, J. S., Newby, G. A., Walter, R. B., Liu, D. R., Mukherjee, S., & Kiem, H.-P. (2025). Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-59713-2

Witte, I. P., Lampe, G. D., Eitzinger, S., Miller, S. M., Berríos, K. N., McElroy, A. N., King, R. T., Stringham, O. G., Gelsinger, D. R., Vo, P. L. H., Chen, A. T., Tolar, J., Osborn, M. J., Sternberg, S. H., & Liu, D. R. (2025). Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase. Science, 388(6748). https://doi.org/10.1126/science.adt5199

Godbout, K., Dugas, M., Reiken, S. R., Ramezani, S., Falle, A., Rousseau, J., Wronska, A. E., Lamothe, G., Canet, G., Lu, Y., Planel, E., Marks, A. R., & Tremblay, J. P. (2025). Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel. International Journal of Molecular Sciences, 26(7), 2835. https://doi.org/10.3390/ijms26072835

da Costa, B. L., Caruso, S. M., Tsai, Y.-T., Castillejos, D. S., Sylla, M., Tsang, S. H., & Quinn, P. M. J. (2025). Prime Editing Strategy to Install the RPE65 c.1430A>G Dominant Mutation. Retinal Degenerative Diseases XX, 101–106. https://doi.org/10.1007/978-3-031-76550-6_17

da Costa, B. L., Pincay, J., Brodie, S. E., Tsang, S. H., & Quinn, P. M. J. (2025). Prime Editing Strategy to Install the Mfrp Retinal Degeneration 6 Mutation. Retinal Degenerative Diseases XX, 113–118. https://doi.org/10.1007/978-3-031-76550-6_19

Zhu, Y., Cai, S. S., Ma, J., Cheng, L., Wei, C., Aggarwal, A., Toh, W. H., Shin, C., Shen, R., Kong, J., Mao, S. A., Lao, Y.-H., Leong, K. W., & Mao, H.-Q. (2024). Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery. Biomaterials, 308, 122559. https://doi.org/10.1016/j.biomaterials.2024.122559

Szekely, O., Rangadurai, A. K., Gu, S., Manghrani, A., Guseva, S., & Al-Hashimi, H. M. (2024). NMR measurements of transient low-populated tautomeric and anionic Watson–Crick-like G·T/U in RNA:DNA hybrids: implications for the fidelity of transcription and CRISPR/Cas9 gene editing. Nucleic Acids Research, 52(5), 2672–2685. https://doi.org/10.1093/nar/gkae027

Papaioannou, V. E., & Behringer, R. R. (2023). Recovering a Targeted Mutation in Mice from Embryonic Stem Cell Chimeras or CRISPR–Cas Founders. Cold Spring Harbor Protocols, 2024(1), pdb.over107959. https://doi.org/10.1101/pdb.over107959

Dubey, S., Chen, Z., Jiang, Y. J., Talis, A., Molotkov, A., Ali, A., Mintz, A., & Momen-Heravi, F. (2024). Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing. Theranostics, 14(7), 2777–2793. https://doi.org/10.7150/thno.92133

George, J. T., Acree, C., Park, J.-U., Kong, M., Wiegand, T., Pignot, Y. L., Kellogg, E. H., Greene, E. C., & Sternberg, S. H. (2023). Mechanism of target site selection by type V-K CRISPR-associated transposases. Science, 382(6672). https://doi.org/10.1126/science.adj8543

Tang, S., & Sternberg, S. H. (2023). Genome editing with retroelements. Science, 382(6669), 370–371. https://doi.org/10.1126/science.adi3183

Girish, V., Lakhani, A. A., Thompson, S. L., Scaduto, C. M., Brown, L. M., Hagenson, R. A., Sausville, E. L., Mendelson, B. E., Kandikuppa, P. K., Lukow, D. A., Yuan, M. L., Stevens, E. C., Lee, S. N., Schukken, K. M., Akalu, S. M., Vasudevan, A., Zou, C., Salovska, B., Li, W., … Sheltzer, J. M. (2023). Oncogene-like addiction to aneuploidy in human cancers. Science, 381(6660). https://doi.org/10.1126/science.adg4521

Lao, Y.-H., Ji, R., Zhou, J. K., Snow, K. J., Kwon, N., Saville, E., He, S., Chauhan, S., Chi, C.-W., Datta, M. S., Zhang, H., Quek, C. H., Cai, S. S., Li, M., Gaitan, Y., Bechtel, L., Wu, S.-Y., Lutz, C. M., Tomer, R., … Leong, K. W. (2023). Focused ultrasound–mediated brain genome editing. Proceedings of the National Academy of Sciences, 120(34). https://doi.org/10.1073/pnas.2302910120

Vaitsiankova, A., Thakar, T., & Ciccia, A. (2023). Base-editing screens illuminate variant effects in human hematopoiesis. Cell Reports Methods, 3(7), 100541. https://doi.org/10.1016/j.crmeth.2023.100541

Ling, J., Jenny, L. A., Zhou, A., & Tsang, S. H. (2022). Therapeutic Gene Editing in Inherited Retinal Disorders. Cold Spring Harbor Perspectives in Medicine, 13(4), a041292. https://doi.org/10.1101/cshperspect.a041292

Schimmel, J., Muñoz-Subirana, N., Kool, H., van Schendel, R., van der Vlies, S., Kamp, J. A., de Vrij, F. M. S., Kushner, S. A., Smith, G. C. M., Boulton, S. J., & Tijsterman, M. (2023). Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways. Cell Reports, 42(2), 112019. https://doi.org/10.1016/j.celrep.2023.112019

Patel, A., Iannello, G., Diaz, A. G., Sirabella, D., Thaker, V., & Corneo, B. (2022). Efficient Cas9‐based Genome Editing Using CRISPR Analysis Webtools in Severe Early‐onset‐obesity Patient‐derived iPSCs. Current Protocols, 2(8). Portico. https://doi.org/10.1002/cpz1.519

Eisenson, D. L., Hisadome, Y., & Yamada, K. (2022). Progress in Xenotransplantation: Immunologic Barriers, Advances in Gene Editing, and Successful Tolerance Induction Strategies in Pig-To-Primate Transplantation. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.899657

Ivanova, E. (2022). How Various Drug Delivery Methods Could Aid in the Translation of Genome Prime Editing Technologies. Genetics Research, 2022, 1–8. https://doi.org/10.1155/2022/7301825

Nambiar, T. S., Baudrier, L., Billon, P., & Ciccia, A. (2022). CRISPR-based genome editing through the lens of DNA repair. Molecular Cell, 82(2), 348–388. https://doi.org/10.1016/j.molcel.2021.12.026

Wang, N.-K., Liu, P.-K., Kong, Y., Levi, S. R., Huang, W.-C., Hsu, C.-W., Wang, H.-H., Chen, N., Tseng, Y.-J., Quinn, P. M. J., Tai, M.-H., Lin, C.-S., & Tsang, S. H. (2021). Mouse Models of Achromatopsia in Addressing Temporal “Point of No Return” in Gene-Therapy. International Journal of Molecular Sciences, 22(15), 8069. https://doi.org/10.3390/ijms22158069